• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Transcend lands $51 million for micro-stent technology | Funding Roundup

Transcend lands $51 million for micro-stent technology | Funding Roundup

July 21, 2011 By MassDevice staff

Transcend Medical

Transcend Medical Inc. closed a second tranche of its series B financing round, bringing its total take to $51 million.

The Menlo Park, Calif.-based company develops ophthalmic devices for minimally invasive glaucoma therapies, and plans to use the newly raised funds for development of additional infrastructure and resources for a U.S. study of its CyPass micro-stent technology, as well as for development of next-generation glaucoma therapies.

The Cypass micro-stent is a tiny implant inserted into the eye through a minimally invasive surgical procedure for the treatment of glaucoma that may eliminate the need for medication, according to the press release.

New interest Investor Growth Capital put some skin in the company during this tranche, joining existing investors Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners.

Transcend Medical CMO Sean Ianchuleve was recently named to the witness list for this week’s House Energy & Commerce Committee’s oversight subcommittee meeting to examine the FDA’s performance in clearing medical devices for the U.S. market.

Funding

Here’s a roundup of other dealflow and investment news:

  • MoMelan closes in on $5 million funding round

    Skin graft technology company MoMelan
    Technologies Inc. raised nearly $4.8 million of a $5 million equity round spread across 18 investors, according to SEC filings. The Cambridge, Mass.-based Momelan makes a device that expands the surface area of skin grafts for treatment of skin disorders.
    Read more
  • Intervention Insights raises $7.2 million
    Grand Rapids, Mich.-based Intervention Insights closed a $7.2 million funding round to expand commercialization of its health care information technology platform, which helps oncologists develop individualized patient treatment plans.
    Read more
  • NeuroWave stalks $5 million investment
    Anesthesia monitoring device company NeuroWave Systems is looking out for $5 million dollars to fund the European commercialization of its anesthesia/sedation monitoring products, MedCity News reported.
    Read more
  • National Science Foundation hands out $18.5 million for neural engineering
    The National Science Foundation awarded $18.5 million to eight institutions to form a sensorimotor neural engineering center at the University of Washington. The center, which is to launch this month, will work on robot devices that assist and understand the nervous system, according to an MIT press release.
    Read more
  • Greenway files for initial public offering
    Electronic health record provide Greenway Medical Technologies Inc. registered a proposed initial public offering of shares of common stock last week. Quantity and pricing of shares hasn’t been determined just yet.
    Read more

Filed Under: Business/Financial News, Funding Roundup, News Well Tagged With: Greenway Medical Technologies Inc., Intervention Insights, MoMelan Technologies, National Science Foundation (NSF), NeuroWave Systems Inc., Transcend Medical Inc., Venture Capital/Private Equity

More recent news

  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy